Literature DB >> 3553250

Blood eosinophilia as a severity marker for bullous pemphigoid.

P Bernard, J Venot, F Constant, J M Bonnetblanc.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3553250     DOI： 10.1016/s0190-9622(87)80227-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  12 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

3.  Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid.

Authors:  Ágnes Kinyó; Anita Hanyecz; Zsuzsanna Lengyel; Dalma Várszegi; Péter Oláh; Csaba Gyömörei; Endre Kálmán; Tímea Berki; Rolland Gyulai
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

Review 4.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

5.  Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.

Authors:  S Morteza Seyed Jafari; Karolina Gadaldi; Laurence Feldmeyer; Nikhil Yawalkar; Luca Borradori; Christoph Schlapbach
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

6.  Correlation of dermal and blood eosinophilia with bullous pemphigoid disease severity.

Authors:  Farshad Farnaghi; Amir-Hooshang Ehsani; Kambiz Kamyab-Hesary; Sepideh Abbasian; Hasan Seirafi; Maryam Nasimi
Journal:  Int J Womens Dermatol       Date:  2020-02-12

Review 7.  Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.

Authors:  Karim Chouchane; Giovanni Di Zenzo; Dario Pitocco; Laura Calabrese; Clara De Simone
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

Review 8.  IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.

Authors:  Ariadne Hadjikyriacou Saniklidou; Patrick J Tighe; Lucy C Fairclough; Ian Todd
Journal:  Arch Dermatol Res       Date:  2017-10-25       Impact factor: 3.017

9.  High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid.

Authors:  Hiroshi Koga; Kwesi Teye; Norito Ishii; Chika Ohata; Takekuni Nakama
Journal:  Front Med (Lausanne)       Date:  2018-05-09

Review 10.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.